© Springer International Publishing Switzerland 2015
Daniel J. Stein and Reza Shaker (eds.)Inflammatory Bowel Disease10.1007/978-3-319-14072-8_11. Why Did This Happen to Me? Epidemiology, Genetics, and Pathophysiology of IBD
(1)
Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, 9th Floor, Boston, MA 02114, USA
Keywords
Crohn’s diseaseGeneticsNOD2SmokingVitamin DAppendectomyAntibioticsEpidemiologyEnvironmentMicrobiomeDietFiberSuggested Response to the Patient
Crohn’s disease and ulcerative colitis, together termed inflammatory bowel diseases, are diseases that affect mostly the large and small intestine. They are characterized by inflammation in the intestine that sometimes is more active and, at other times, stays quiet or in remission. The exact reason why people develop these conditions is not known, but several possible reasons have been proposed. As infants develop over the first 2–4 years of life, they establish a pattern of bacteria in their intestine. This varies between different individuals but there are broad patterns. There are also immune cells that develop in the lining of the intestine that is meant to ignore one’s normal bacteria or “good bacteria” but attack potential invading organisms such as those causing food poisoning or “bad bacteria.” For reasons that are not completely clear, in some individuals the immune cells lose the ability to recognize the bacterial pattern as being normal or your own and start making chemicals called cytokines that lead to inflammation and subsequent damage to the lining. We think that there is a definite contribution of genetics to this; a family history of IBD is one of the strongest risk factors for developing disease in an individual. But there are also additional important contributions from the patterns of bacteria in the intestine; for example, studies have shown that the patterns of bacteria in people developing Crohn’s disease or ulcerative colitis are different from those who do not. Additionally there is also an important contribution of the external environment in influencing both the pattern of bacteria and the immune system response. These may include factors such as smoking, diet, use of antibiotics, and stress or depression. There are approximately 1–1.5 million people in the USA with inflammatory bowel disease, so most people know at least one person with IBD.
Brief Review of Literature
Epidemiology
Inflammatory bowel disease that consists of Crohn’s disease and ulcerative colitis is most commonly found in North America and Europe, but it can be found worldwide. There are approximately 1–1.5 million people with IBD living in the USA and 2.2 million people in Europe. The incidence of UC ranges from 0.6 to 24.3 persons in Europe and North America with a lower incidence in Asia. The incidence of Crohn’s disease is similar as well between 0.3 and 20.2 per 100,000 persons in North America. The estimated prevalence of these diseases is as high as 505 per 100,000 individuals for ulcerative colitis and 322 per 100,000 persons for Crohn’s disease in Europe. The incidence and prevalence of these diseases appear lower in Asia but are increasing. The peak age of diagnosis is between 20 and 30 years with a second peak variably reported between 60 and 70 years. The incidence seems similar across both genders. There are also some ethnic differences with these diseases being more common in those of Jewish ancestry but uncommon in other populations like the First Nations population in Canada.